AdaptHealth Corp

For the period ended Dec 31, 2024. Filed Feb 25, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 25, 2025

AHCO$7.33-1.1%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 25, 2025.

AdaptHealth Corp.
By:	/s/ Suzanne Foster
	Suzanne Foster
	Chief Executive Officer and Director

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Suzanne Foster and Richard Rew, jointly and severally, his attorney-in-fact, each with the full power of substitution, for such person, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might do or could do in person hereby ratifying and confirming all that each of said attorneys-in-fact and agents, or his substitute, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on February 25, 2025 by the following persons on behalf of the registrant and in the capacities indicated:

Signature		Title
By:	/s/ Suzanne Foster		Chief Executive Officer and Director
	Suzanne Foster		(Principal Executive Officer)
By:	/s/ Jason Clemens		Chief Financial Officer
	Jason Clemens		(Principal Financial Officer)
By:	/s/ Christine E. Archbold		Chief Accounting Officer
	Christine E. Archbold		(Principal Accounting Officer)
By:	/s/ Dale Wolf		Chairman of the Board
	Dale Wolf
By:	/s/ Gregory A. Belinfanti		Director
	Gregory A. Belinfanti
By:	/s/ Terence Connors		Director
	Terence Connors
By:	/s/ Bradley Coppens		Director
	Bradley Coppens
By:	/s/ Theodore S. Lundberg		Director
	Theodore S. Lundberg
By:	/s/ Diana Nole		Director
	Diana Nole
By:	/s/ Dr. Susan Weaver		Director
	Dr. Susan Weaver
By:	/s/ David S. Williams III		Director
	David S. Williams III

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.